Tempus AI Other Share Holders Equity 2023-2025 | TEM

Tempus AI other share holders equity from 2023 to 2025. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Tempus AI other share holders equity for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
  • Tempus AI other share holders equity for 2024 was $0B, a 0% decline from 2023.
  • Tempus AI other share holders equity for 2023 was $0B, a 0% decline from 2022.
  • Tempus AI other share holders equity for 2022 was $0B, a 0% decline from .
Tempus AI Annual Other Share Holders Equity
(Millions of US $)
2024 $0
2023 $0
2022 $0
Tempus AI Quarterly Other Share Holders Equity
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $12.011B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.227B 59.07
Hims & Hers Health (HIMS) United States $12.367B 128.49
IRhythm Technologies (IRTC) United States $4.742B 0.00
Inspire Medical Systems (INSP) United States $4.033B 63.01
Hinge Health (HNGE) United States $2.855B 0.00
Privia Health (PRVA) United States $2.804B 191.67
Schrodinger (SDGR) United States $1.917B 0.00
Enovis (ENOV) United States $1.916B 10.69
Phreesia (PHR) United States $1.667B 0.00
Clover Health Investments (CLOV) United States $1.522B 0.00
Omnicell (OMCL) United States $1.463B 25.82
Azenta (AZTA) United States $1.393B 64.72
10x Genomics (TXG) United States $1.311B 0.00
Fulgent Genetics (FLGT) United States $0.663B 0.00
Butterfly Network (BFLY) United States $0.645B 0.00
Claritev (CTEV) United States $0.631B 0.00
Talkspace (TALK) United States $0.499B 149.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.372B 824.33
Outset Medical (OM) United States $0.366B 0.00
Health Catalyst (HCAT) United States $0.288B 0.00
Nyxoah SA (NYXH) Belgium $0.266B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.148B 0.00
Pulmonx (LUNG) United States $0.137B 0.00
EUDA Health Holdings (EUDA) Singapore $0.124B 0.00
American Well (AMWL) United States $0.115B 0.00
MDxHealth SA (MDXH) Belgium $0.102B 0.00
CareCloud (CCLD) United States $0.094B 3.60
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.030B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
Precipio (PRPO) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00